TY - JOUR T1 - Adenoma detection rate in fecal immunochemical test positive colonoscopies: a population-based observational study JF - medRxiv DO - 10.1101/2020.08.31.20185124 SP - 2020.08.31.20185124 AU - Bernard Denis AU - Isabelle Gendre AU - Nicolas Tuzin AU - Anne Guignard AU - Philippe Perrin AU - Gabriel Rahmi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/02/2020.08.31.20185124.abstract N2 - Background and aims Neoplasia-related indicators, such as adenoma detection rate (ADR), are a priority in the quality improvement process for colonoscopy. Our aim was to assess and compare different detection and characterization indicators in fecal occult blood test (FOBT)-positive colonoscopies, to analyze the factors influencing their variance, and to propose benchmarks.Methods Retrospective analysis of prospectively collected data from all colonoscopies performed between 2007 and 2019 after a positive guaiac-based FOBT or a fecal immunochemical test (FIT) in the population-based colorectal cancer (CRC) screening program conducted in Alsace, part of the French national program. Detection indicators included ADR, NewADR (including proximal serrated lesions), mean number of adenomas per colonoscopy, and proximal serrated lesion detection rate. Characterization indicators included non-neoplastic polyp detection rate.Results Overall, 13.455 FIT-positive colonoscopies were performed by 116 endoscopists. The overall ADR was 57.6% (95%CI 56.8-58.5). For each 10 μg/g increase in fecal hemoglobin concentration, a 2% increase in ADR was observed. Endoscopists whose ADR was ≥55% were high detectors for all neoplasia, including proximal serrated lesions and number of adenomas. The non-neoplastic polyp detection rate was 39.5% in highest detectors (ADR >70%), significantly higher than in lower detectors (21.4%) (p<0.001). There was a strong correlation between detection and characterization indicators, e.g. between proximal serrated lesion and non-neoplastic polyp detection rates (Pearson = 0.73; p<0.01).Conclusions A single indicator, NewADR, including proximal serrated lesions, is enough to assess the neoplasia yield of colonoscopy provided the target standard is raised between 55% and 70% in FIT-positive colonoscopies (65-80% in men, 45-60% in women).Competing Interest StatementPr Gabriel Rahmi reports personal fees from Medtronic, Fujifilm, and grants from Norgine. None declared for other authorsFunding StatementThis study was performed as part of a quality assurance program within the French national CRC screening program without dedicated funding. The sources of funding of the national program include the French statutory health insurance scheme (Assurance Maladie), the French Ministry of Health and some regional Administrations. They had no role in study design, data collection, analysis, and interpretation, or writing the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was exempt from institutional review board approval because individual participants were not approached, only routinely collected data were utilised and all data were anonymized for the purposes of quality improvement within the screening program. The study was performed in accordance with the declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll deidentified participant data are available upon reasonable request from IG isabelle.gendre{at}adeca-alsace.fr ER -